Featured Research

from universities, journals, and other organizations

Cell behavior mapped in low oxygen conditions, may lead to cancer treatment

Date:
February 20, 2014
Source:
University of Liverpool
Summary:
Research has explained how cells behave when placed in a low oxygen environment, a development that could have implications for cancer patients and other serious illnesses. The findings open up the possibility of controlling the signals that keep cells alive, preventing the damages caused by ischemia -- a restriction of blood supply to tissues. It could also work to help destroy cancer cells.

Research at the University of Liverpool has explained how cells behave when placed in a low oxygen environment, a development that could have implications for cancer patients and other serious illnesses.

The research opens up the possibility of controlling the signals that keep cells alive, preventing the damages caused by ischemia -- a restriction of blood supply to tissues. It could also work to help destroy cancer cells.

When the body is deprived of adequate oxygen supply it is known as hypoxia and can cause the death of cells. This occurs in patients suffering from 'ischemia', which can lead to gangrene or paralysis.

A reduction in oxygen levels, such as that used in the new study and which mimics the situation in a tumor, causes cells to adapt to the new environment and become resistant.

The researchers from the Institute of Integrative Biology in collaboration with researchers from the Department of Mathematical Sciences at the University, subjected cells to conditions with only 1% oxygen for 20 hours, and imaged the cellular response in real-time. They then mathematically modelled the profile of the proteins which conveyed instructions telling the cells how to behave.

It has not been established before why some cells died and others lived under low oxygen conditions, but by monitoring the levels of proteins in the cells and observing how they influenced genes switching on in the cells, the researchers were able to determine the optimum conditions for keeping cells alive.

Cell biologist, Dr Violaine See, who led the project, said: "These findings could have important consequences for how we understand tumors, which are hypoxic because of the rapid cell growth which outpaces their blood supply."

The study was published in the Journal of Biological Chemistry


Story Source:

The above story is based on materials provided by University of Liverpool. Note: Materials may be edited for content and length.


Journal Reference:

  1. J. Bagnall, J. Leedale, S. Taylor, D. G. Spiller, M. R. H. White, K. J. Sharkey, R. N. Bearon, V. See. Tight control of Hypoxia Inducible Factor (HIF)-alpha transient dynamics is essential for cell survival in hypoxia. Journal of Biological Chemistry, 2014; DOI: 10.1074/jbc.M113.500405

Cite This Page:

University of Liverpool. "Cell behavior mapped in low oxygen conditions, may lead to cancer treatment." ScienceDaily. ScienceDaily, 20 February 2014. <www.sciencedaily.com/releases/2014/02/140220102919.htm>.
University of Liverpool. (2014, February 20). Cell behavior mapped in low oxygen conditions, may lead to cancer treatment. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/02/140220102919.htm
University of Liverpool. "Cell behavior mapped in low oxygen conditions, may lead to cancer treatment." ScienceDaily. www.sciencedaily.com/releases/2014/02/140220102919.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins